Differential reactivity of cardiac and skeletal muscle from various species in a cardiac troponin I immunoassay
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
To identify a blood test that can differentiate cardiac from skeletal muscle injury in animals, we compared tissue reactivities for various species with the use of an immunoassay for human cardiac troponin I (cTnI). Tissue reactivity varied as a function of the homology of tissue troponin with human cTnI. Cardiac reactivity in large mammals was equivalent to cTnI, 9.8 ± 0.6 mg/g, and was 2-fold, 10-fold, and 100-fold greater than in small mammals, birds, and fish, respectively. Skeletal muscle reactivity was equivalent to cTnI, 5.1 ± 0.6 μg/g, in all species except fish, in which it was 50% lower. The ratio of reactivities of cardiac and skeletal muscle was: 1800 in large mammals, 1100 in small mammals, 230 in birds, and 43 in fish. We conclude that cTnI is a powerful candidate in mammals, a possible candidate in birds, but unlikely to be of use in fish as a sensitive and tissue-selective diagnostic test for cardiac injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
Schägger, H., & von Jagow, G. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90587-2 · Cited by 11,444
The SWISS-PROT protein sequence data bank and its supplement TrEMBL
Bairoch, A., & Apweiler, R. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.1.31 · Cited by 3,587
The SWISS-PROT protein sequence data bank and its supplement TrEMBL in 1998
Bairoch, A. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.1.38 · Cited by 3,280
Antman, E. M., Tanasijevic, M. J., Thompson, B., Schactman, M., McCabe, C. H., Cannon, C. P., Fischer, G. A., Fung, A. Y., Thompson, C., Wybenga, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351802 · Cited by 1,749
Cardiac troponin I. A marker with high specificity for cardiac injury.
Adams, J. E., Bodor, G. S., Dávila-Román, V. G., Delmez, J. A., Apple, F. S., Ladenson, J. H., & Jaffe, A. S. (1993) · Circulation · doi:10.1161/01.cir.88.1.101 · Cited by 1,148 · cited 1×
“cTnI is a sensitive and persistent indicator of cardiac injury in humans [8, 12, 13], with high tissue specificity in the presence of marked skeletal muscle injury [6–8] and chronic renal failure [6, 8, 9, 14].”
Self-citationKatus, H. A., Remppis, A., Scheffold, T., Diederich, K. W., & Kuebler, W. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90466-x · Cited by 556 · cited 1×
“Increases in serum cTnI after myocardial injury are persistent; the diagnostic window after myocardial infarction in humans is at least 9 days for cTnI [20, 21], which is longer than increases of CK-MB [20, 22] and comparable with cTnT, although some evidence suggests that cTnT remains increased longer [22, 23].”
Diagnosis of Perioperative Myocardial Infarction with Measurement of Cardiac Troponin I
Adams, J. E., Sicard, G. A., Allen, B. T., Bridwell, K. H., Lenke, L. G., Davila-Roman, V. G., Bodor, G. S., Ladenson, J. H., & Jaffe, A. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403103301003 · Cited by 527 · cited 1×
“cTnI is a sensitive and persistent indicator of cardiac injury in humans [8, 12, 13], with high tissue specificity in the presence of marked skeletal muscle injury [6–8] and chronic renal failure [6, 8, 9, 14].”
Self-citationThe SWISS-PROT protein sequence data bank and its new supplement TREMBL
Bairoch, A. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.1.21 · Cited by 488 · cited 3×
“the cTnI immunoassay can be attributed primarily to species differences in the primary structure of the protein [30] (Fig.”
InfluentialBodor, G. S., Porter, S., Landt, Y., & Ladenson, J. H. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.11.2203 · Cited by 425 · cited 4×
“The concentration of cTnI was determined with a research-application, sandwich enzyme immunoassay (Stratus I, Dade International) in which two cTnI-specific murine monoclonal antibodies [ 20 ] are used, 2F6.6 as the capture antibody and 2B1.9 as the labeling antibody.”
BackgroundMethodInfluentialSelf-citationBodor, G. S., Porterfield, D., Voss, E. M., Smith, S., & Apple, F. S. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.12.1710 · Cited by 311 · cited 1×
“Additionally, cTnI expression has not been detected in fetal or diseased skeletal muscle [15], although cTnT and CK-MB may be upregulated with chronic muscle injury [16, 17], and CK-MB is upregulated with endurance training [18, 19].”
Larue, C., Calzolari, C., Bertinchant, J. P., Leclercq, F., Grolleau, R., & Pau, B. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.6.972 · Cited by 265 · cited 1×
“Increases in serum cTnI after myocardial injury are persistent; the diagnostic window after myocardial infarction in humans is at least 9 days for cTnI [20, 21], which is longer than increases of CK-MB [20, 22] and comparable with cTnT, although some evidence suggests that cTnT remains increased longer [22, 23].”
Effect of Exercise on Serum Enzyme Activities in Humans
Noakes, T. D. (1987) · Sports Medicine · doi:10.2165/00007256-198704040-00003 · Cited by 245 · cited 1×
“Additionally, cTnI expression has not been detected in fetal or diseased skeletal muscle [15], although cTnT and CK-MB may be upregulated with chronic muscle injury [16, 17], and CK-MB is upregulated with endurance training [18, 19].”
Cardiac troponin T in diagnosis of acute myocardial infarction
Mair, J., Artner-Dworzak, E., Lechleitner, P., Smidt, J., Wagner, I., Dienstl, F., & Puschendorf, B. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.6.845 · Cited by 223
Biochemical markers of myocardial damage
Bhayana, V., & Henderson, A. R. (1995) · Clinical Biochemistry · doi:10.1016/0009-9120(94)00065-4 · Cited by 201
Jaffe, A. S., Landt, Y., Parvin, C. A., Abendschein, D. R., Geltman, E. M., & Ladenson, J. H. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.11.1770 · Cited by 197 · cited 2×
“Because this method overestimates cTnI concentrations fivefold compared with the Lowry assay [28] (data not shown), the tissue reactivities are fivefold greater than would be obtained by the current, commercially available cTnI immunoassay (Stratus II, Dade International) [29]. calculations and statistical analysis Ti…”
Self-citationMyocardial Markers of Injury:Evolution and Insights
Keffer, J. H. (1996) · American Journal of Clinical Pathology · doi:10.1093/ajcp/105.3.305 · Cited by 128 · cited 1×
“Furthermore, the more sensitive and specific immunoassays for mass CK-MB and cardiac troponin T (cTnT) that are used to diagnose myocardial infarction in humans [4, 5] may also be unreliable with skeletal muscle injury [6–8] or chronic renal disease [6, 9–11].”
Syska, H., PERRY, S. V., & Trayer, I. P. (1974) · FEBS Letters · doi:10.1016/0014-5793(74)80238-3 · Cited by 125 · cited 1×
“Purified canine cTnI and sTnI was prepared from canine heart and skeletal muscle [27] and used as controls.”
Spinale, F. G., Zellner, J. L., Tomita, M., Crawford, F. A., & Zile, M. R. (1991) · Circulation Research · doi:10.1161/01.res.69.4.1058 · Cited by 124 · cited 1×
“In ventricular and myocyte remodeling during the development of heart failure, a moderate reduction in the content of myofibrils, of which cTnI is a component, occurs [32].”
Serum enzymes in the diagnosis of disease in man and animals
Boyd, J. (1988) · Journal of Comparative Pathology · doi:10.1016/0021-9975(88)90088-6 · Cited by 67
CK and LD isozymes in human single muscle fibers in trained athletes
Apple, F. S., & Tesch, P. A. (1989) · Journal of Applied Physiology · doi:10.1152/jappl.1989.66.6.2717 · Cited by 42 · cited 1×
“Additionally, cTnI expression has not been detected in fetal or diseased skeletal muscle [15], although cTnT and CK-MB may be upregulated with chronic muscle injury [16, 17], and CK-MB is upregulated with endurance training [18, 19].”
O'Brien, P. J. (1997) · American Journal of Veterinary Research · doi:10.2460/ajvr.1997.58.01.11 · Cited by 31 · cited 2×
“In Doberman pinscher dogs with heart failure, the 32% lower (than healthy controls) cTnI concentration can be attributed to lower myofibril content of myocardium [25] and matches the 30% lower concentration of cTnT found in myocardium of the same breed of dogs with the same cardiomyopathy [25].”
Self-citationSylvén, C., Jansson, E., & Olin, C. L. (1983) · Clinical Physiology · doi:10.1111/j.1475-097x.1983.tb00854.x · Cited by 28 · cited 1×
“Additionally, cTnI expression has not been detected in fetal or diseased skeletal muscle [15], although cTnT and CK-MB may be upregulated with chronic muscle injury [16, 17], and CK-MB is upregulated with endurance training [18, 19].”
Cited by
Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals
O'Brien, P. J., Smith, D. E. C., Knechtel, T. J., Marchak, M. A., Pruimboom-Brees, I., Brees, D. J., Spratt, D. P., Archer, F. J., Butler, P., Potter, A. N., et al. (2006) · Laboratory Animals · doi:10.1258/002367706776319042 · Cited by 307
Self-citationO’Brien, P. J. (2008) · Toxicology · doi:10.1016/j.tox.2007.12.006 · Cited by 270
Self-citationCardiac troponin I: evaluation of a biomarker for the diagnosis of heart disease in the dog
Spratt, D. P., Mellanby, R. J., Drury, N., & Archer, J. (2005) · Journal of Small Animal Practice · doi:10.1111/j.1748-5827.2005.tb00304.x · Cited by 237
Metadata
- Authors
- O’Brien, P. J., Landt, Y., & Ladenson, J. H.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-12-01
- Volume
- 43
- Issue
- 12
- Pages
- 2333-2338
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W1914963914
- Cited by
- 173
- References
- 24
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.